Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 29 citing articles:

Mechanism and medical implications of mammalian autophagy
Ivan Ðikić, Zvulun Elazar
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 6, pp. 349-364
Closed Access | Times Cited: 2378
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 97
Role of autophagy in breast cancer and breast cancer stem cells (Review)
Yanyan Han, Shujun Fan, Tao Qin, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 112
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
David Austin, Nalo Hamilton, Yahya Elshimali, et al.
Oncotarget (2018) Vol. 9, Iss. 74, pp. 33912-33930
Open Access | Times Cited: 52
IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer
Jonathan Zorea, Manu Prasad, Limor Cohen, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 40
Autophagy-related 7 modulates tumor progression in triple-negative breast cancer
Mingyang Li, Jingwei Liu, Sihui Li, et al.
Laboratory Investigation (2019) Vol. 99, Iss. 9, pp. 1266-1274
Open Access | Times Cited: 35
Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies
Malina Xiao, Alice Benoit, Meriem Hasmim, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 25
Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1
Alessia D’Aloia, Michela Ceriani, Renata Tisi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7145-7145
Open Access | Times Cited: 18
Picropodophyllotoxin alters EMT in neuroblastoma via inhibition of surface receptors IFG1R and ALK
Poonam Bhagriya, Afridi Shaikh, Hetal Roy
Growth Hormone & IGF Research (2025) Vol. 80, pp. 101638-101638
Closed Access
β-elemene induced apoptosis and senescence of triple-negative breast cancer cells through IGF1/IGF1R pathway
Lufan Xie, Jianfeng Zhang, Haibin Yan, et al.
Tissue and Cell (2022) Vol. 79, pp. 101914-101914
Closed Access | Times Cited: 15
Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer
Ferenc Sípos, Hajnal Székely, Imre Dániel Kis, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 46, pp. 8109-8119
Open Access | Times Cited: 28
The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis
Jun Zhao, Xuefeng Shi, Tao Wang, et al.
Cellular Physiology and Biochemistry (2017) Vol. 43, Iss. 2, pp. 697-704
Open Access | Times Cited: 20
Icariside II suppresses the tumorigenesis and development of ovarian cancer by regulating miR‐144‐3p/IGF2R axis
Donglan Yuan, Ting Guo, Hua Qian, et al.
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1383-1393
Closed Access | Times Cited: 11
Loss of Proprotein Convertase Furin in Mammary Gland Impairs proIGF1R and proIR Processing and Suppresses Tumorigenesis in Triple Negative Breast Cancer
Zongsheng He, Abdel‐Majid Khatib, John W.M. Creemers
Cancers (2020) Vol. 12, Iss. 9, pp. 2686-2686
Open Access | Times Cited: 16
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
Nalo Hamilton, David Austin, Diana C. Márquez‐Garbán, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2305-2305
Open Access | Times Cited: 16
Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response
Ferenc Sípos, Bettina Bohusné Barta, Ágnes Simon, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 8
Phyla nodiflora L. Extracts Induce Apoptosis and Cell Cycle Arrest in Human Breast Cancer Cell Line, MCF-7
Peik Lin Teoh, Monica Liau, Bo Eng Cheong
Nutrition and Cancer (2019) Vol. 71, Iss. 4, pp. 668-675
Closed Access | Times Cited: 12
Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: implications for treatment and discovery of potential therapeutic signatures
Jian Li, Kathrin Halfter, Mengying Zhang, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy
Sarbjit Singh, Divya Utreja, Vimal Kumar
Medicinal Chemistry Research (2021) Vol. 31, Iss. 1, pp. 1-25
Open Access | Times Cited: 10
CDK4/6 inhibitor enhances the radiosensitization of esophageal squamous cell carcinoma (ESCC) by activating autophagy signaling via the suppression of mTOR.
Wenjun Qin, Yi-Ge Su, Xiao-Long Ding, et al.
PubMed (2022) Vol. 14, Iss. 3, pp. 1616-1627
Closed Access | Times Cited: 7
The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia
Soudeh Ghafouri‐Fard, Atefe Abak, Mahdi Mohaqiq, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 9
Recent update on IGF-1/IGF-1R signaling axis as a promising therapeutic target for triple-negative breast cancer
Shashank Kumar, Smriti Chaudhri
Pathology - Research and Practice (2024) Vol. 263, pp. 155620-155620
Closed Access
Dual Therapy with Insulin-Like Growth Factor-I Receptor/Insulin Receptor (IGF1R/IR) and Androgen Receptor (AR) Antagonists Inhibits Triple-Negative Breast Cancer Cell Migration In Vitro
Nalo Hamilton, Diana C. Márquez‐Garbán, Ben Rogers, et al.
(2019) Vol. 2, Iss. 2
Closed Access | Times Cited: 2
Contribution of Autophagy in Acquired Drug Resistance of Human Breast Cancer Cells MCF7 to Doxorubicin
Nahid Amani, Fatemeh Shaki, Mohammad Shokrzadeh
Applied In Vitro Toxicology (2019) Vol. 5, Iss. 4, pp. 173-179
Closed Access | Times Cited: 2
3D QSAR and pharmacophore studies on inhibitors of insuline like growth factor 1 receptor (IGF-1R) and insulin receptor (IR) as potential anti-cancer agents
Mustafa Kamal Pasha, Ishrat Jabeen, Sandhya Samarasinghe
Current Research in Chemical Biology (2022) Vol. 2, pp. 100019-100019
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top